Cannabis Rescheduling

Missouri Issues Cannabis Rescheduling Guidelines, Warns Licensees to Follow State Law

The state’s Division of Cannabis Regulation cautioned licensees not to participate in interstate commerce under a federal Schedule III listing.

DEA Rules for Schedule III Medical Cannabis Registrants Pose Major Disruptions to State Programs

The agency granted federal registration to more than 900 of 7,000 priority applicants, forbidding them from doing business with non-registered entities.

US Congressman Introduces Bill to Legalize Cannabis, Rewrite Controlled Substances Act

The ‘Public Health and Research Reforms in Controlled Substances Act’ would deschedule cannabis and overhaul 50-plus years of drug scheduling policies.

New Schedule III Registration Portal’s Opening Leads CBT’s Top Stories in October

The new application process is for state-licensed medical cannabis manufacturers, distributors and testing laboratories.

DEA Judge Rejects Anti-Rescheduling Plea to Reopen Cannabis Hearing, Allows New Briefs

The judge granted a motion for written legal arguments on a recent GAO report to be included in the record, but he won’t allow new testimony or evidence.

DEA Pushes Judge to Wrap Up Rescheduling Process, Avoid Prohibitionist Bait

The Drug Enforcement Administration urged the judge to squash an anti-rescheduling motion to reopen the hearing for new testimony and discovery.

Cannabis Rescheduling Process Remains Sidelined, DEA Judge Orders New Replies

The judge overseeing the process granted a new request from anti-rescheduling parties as he considers reopening the hearing for more testimony.

DEA Objects to Additional Rescheduling Briefing Request by Prohibitionists, Defers to Judge

The DEA claims anti-rescheduling parties ‘mischaracterized’ a new report that found ‘gaps’ in the government’s scheduling policies.

South Dakota AG Determines Federal Cannabis Rescheduling Won’t Impact State Program

Attorney General Marty Jackley issued an opinion that the feds’ Schedule III listing won’t change the state’s medical cannabis program.

DEA Opens New Schedule III Registration Portal for Medical Cannabis Manufacturers, Distributors, Labs

State-licensed medical cannabis businesses can use the new Form 225 application process to register under the Controlled Substances Act.

'Where Are We on Rescheduling?' Leads CBT’s Top Stories in September

Former federal prosecutor and CBT contributor Julie A. Werner-Simon breaks down where we are months after the U.S. Attorney General’s April order.

DEA Judge Halts Cannabis Rescheduling Process, May Reopen Hearing Record

The judge who oversaw the hearing proceedings granted anti-rescheduling parties a stay over a new report that found ‘gaps’ in the DEA’s scheduling policies.

Page 1 of 22

Next Page